Skip to content
Uncommon Cures
  • Home
  • For Sponsors
    • Who We Are
    • When To Bring Us In
    • What We Do
    • How We Work
    • Why Us
    • Sponsor FAQ
  • Patients & Families
    • What is Uncommon Cures?
    • What To Expect
    • Current Trials
      • HARMONY Study for Patients With HCU
      • Phenylketonuria (PKU) Study for Patients Taking Palynziq
      • ARCT-810-04
      • Friedreich’s Ataxia Research in Pediatric Patients
    • Facility
    • Patient FAQ
  • About
    • Who We Are
    • What Sets Us Apart
    • Uncommon Team
    • Our Leadership Model
    • Our Approach
  • Facility
  • Insights
    • News Articles & Press Releases
    • Podcasts & Similar
    • Thought Leadership
  • Home
  • For Sponsors
    • Who We Are
    • When To Bring Us In
    • What We Do
    • How We Work
    • Why Us
    • Sponsor FAQ
  • Patients & Families
    • What is Uncommon Cures?
    • What To Expect
    • Current Trials
      • HARMONY Study for Patients With HCU
      • Phenylketonuria (PKU) Study for Patients Taking Palynziq
      • ARCT-810-04
      • Friedreich’s Ataxia Research in Pediatric Patients
    • Facility
    • Patient FAQ
  • About
    • Who We Are
    • What Sets Us Apart
    • Uncommon Team
    • Our Leadership Model
    • Our Approach
  • Facility
  • Insights
    • News Articles & Press Releases
    • Podcasts & Similar
    • Thought Leadership
Uncommon Cures
  • Home
  • About
    • Our Team
  • What We Do
    • Clinical Trial – Data Collection Study
    • Clinical Trial With Facilities (External Complex)
    • In House Clinical Trial (No External Facilities)
    • Post Marketing Study
    • Rare Disease Study and Design
    • Subject Screening For Clinical Trial
  • Patients
  • News
    • News Articles & Press Releases
    • Podcasts & Similar
    • Thought Leadership
  • Contact Us
  • Home
  • About
    • Our Team
  • What We Do
    • Clinical Trial – Data Collection Study
    • Clinical Trial With Facilities (External Complex)
    • In House Clinical Trial (No External Facilities)
    • Post Marketing Study
    • Rare Disease Study and Design
    • Subject Screening For Clinical Trial
  • Patients
  • News
    • News Articles & Press Releases
    • Podcasts & Similar
    • Thought Leadership
  • Contact Us
  • Contact Us

Day: March 15, 2023

Uncommon Curess, LLC Is Please To Announce That Dr. Tam Roshan Lal Has Joined The Company As Chief Medical Officer.

Medical research

For Immediate Release Uncommon Cures, LLC is pleased to announce that Dr. Tam Roshan Lal has joined the company as Chief Medical Officer. Dr. Roshan Lal is an experienced rare disease clinician with extensive clinical trials experience. Prior to joining Uncommon Cure, she worked as an Attending Metabolic Geneticist at the Rare Disease Institute (RDI), Childrens National […]

Linkedin
A unique clinical trials company using Uncommon Sense(SM)  to bring life-changing therapies to rare disease patients.

Quick Links

  • Home
  • For Sponsors
    • Who We Are
    • When To Bring Us In
    • What We Do
    • How We Work
    • Why Us
    • Sponsor FAQ
  • Patients & Families
    • What is Uncommon Cures?
    • What To Expect
    • Current Trials
      • HARMONY Study for Patients With HCU
      • Phenylketonuria (PKU) Study for Patients Taking Palynziq
      • ARCT-810-04
      • Friedreich’s Ataxia Research in Pediatric Patients
    • Facility
    • Patient FAQ
  • About
    • Who We Are
    • What Sets Us Apart
    • Uncommon Team
    • Our Leadership Model
    • Our Approach
  • Facility
  • Insights
    • News Articles & Press Releases
    • Podcasts & Similar
    • Thought Leadership
  • Home
  • For Sponsors
    • Who We Are
    • When To Bring Us In
    • What We Do
    • How We Work
    • Why Us
    • Sponsor FAQ
  • Patients & Families
    • What is Uncommon Cures?
    • What To Expect
    • Current Trials
      • HARMONY Study for Patients With HCU
      • Phenylketonuria (PKU) Study for Patients Taking Palynziq
      • ARCT-810-04
      • Friedreich’s Ataxia Research in Pediatric Patients
    • Facility
    • Patient FAQ
  • About
    • Who We Are
    • What Sets Us Apart
    • Uncommon Team
    • Our Leadership Model
    • Our Approach
  • Facility
  • Insights
    • News Articles & Press Releases
    • Podcasts & Similar
    • Thought Leadership

Subscribe To Our Newsletter

UNCOMMON CURES® is a registered service mark of Uncommon Cures, Inc.  All other marks and logos are proprietary to Uncommon Cures, Inc., as denoted.  All rights reserved. Copywrite.  2026.

Disclaimer | Imprint | Cookie Policy | Privacy

Do Not Sell or Share My Personal Information